CD4 and CD8 T cells, but not B cells, are critical to the control of murine experimental autoimmune neuritis.
Yu Zhu,Lei Bao,Shunwei Zhu,Zhiguo Chen,Peter van der Meide,Inger Nennesmo,Bengt Winblad,Hans-Gustaf Ljunggren,Jie Zhu
DOI: https://doi.org/10.1006/exnr.2002.7944
IF: 5.62
2002-01-01
Experimental Neurology
Abstract:Experimental autoimmune neuritis (EAN) is a T cell-mediated autoimmune disease of the peripheral nervous system that duplicates the clinical, pathological, and electrophysiological features of Guillain–Barré syndrome in humans. However, the molecular pathogenesis of EAN remains controversial. Therefore, for this study, we induced EAN with P0 protein peptide 180–199 in CD4−/−, CD8−/−, CD4−8−, and B cell knockout (μMT) mice to further investigate the roles of these cells in EAN. Our results showed that the severity of clinical signs and histopathological manifestations of EAN and the T cell response to P0 peptide 180–199 in CD4−/− mice were significantly lower than those in their wild-type counterparts. CD8−/− mice also had a milder clinical course, less histopathological change, and a diminished T cell response to P0 peptide 180–199. However, more severe clinical and histopathological manifestations, a stronger T cell response to P0 peptide 180–199, and enhanced IFN-γ production in the spleen were observed in the EAN of CD4−8− and μMT mice, but these were not obviously different from those of wild-type mice. Levels of IgG production were similar in sera from CD4−/−, CD8−/−, and CD4−8−, and wild-type mice. These findings suggest that the induction and control of murine EAN are dependent on both CD4+ and CD8+ T cells and that B cells apparently do not perpetuate the related inflammatory demyelination.